USPTO serial 79305056
MILTENYI BIOMEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 12, 2022
- Examiner
- PASSMAN, NICOLE A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MILTENYI BIOMEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | industrial chemicals, biological preparations for use in cell cultures, other than for medical or veterinary purposes, biochemical preparations for scientific purposes; acetone for use in separation process for biological materials; reagents for cell separation, labeling reagents, reagents, cell culture media, substances and ingredients for the preparation of cell culture media, all for commercial and scientific purposes and for the use in medical laboratories; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material for scientific and research use; reagents with magnetic beads for scientific and research use; antibody reagents other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments; reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; culture media, cell culture media, freezing media, all for scientific purposes; reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry other than for medical or veterinary purposes | ACTIVE | — |
| 005 | veterinary preparations for treatment of cancer, pharmaceutical preparations for the treatment of cancer; reagents, contrast media, materials and ingredients for the preparation of contrast media, all for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, antibody reagents, all for medical or veterinary purposes; buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media, cell culture media, diagnostic reagents and preparations for medical and veterinary purposes; freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, especially pharmaceutical products in the nature of cell cultures and pharmaceutical preparations for cellular therapy; chemical, biological and biochemical preparations for therapeutic purposes for treatment of cancer; chemical, biological and biochemical diagnostic preparations for medical purposes; diagnostic contrast agents for medical use, contrast agents for in-vivo imaging for medical use | ACTIVE | — |
| 010 | Apparatus, namely, tubes for magnetic cell separation for medical purposes; tubing sets for cell separation for medical purposes; columns for magnetic cell separation for medical analysis cryogenic tubes and cryogenic freezing bags for medical purposes, in particular for cryopreservation; dialysis machines for medical use; apheresis machines for medical use; veterinary apparatus and instruments, namely, centrifugation devices; medical apparatus and instruments, namely, centrifugation devices | ACTIVE | — |
| 016 | Plastic materials for packaging, namely, packaging bags for the cryopreservation of biological and biochemical material, especially cellular material for biological and medical research and therapy | ACTIVE | — |
| 039 | Biological and biochemical storage, especially cryopreserved material for medical, scientific and biotechnological purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design of medical and laboratory equipment; industrial laboratory analysis and research services in the field of biology and medicine; design and development of computer hardware and software for the analysis of biological and biochemical material; all of the aforementioned services for and in connection with the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy | ACTIVE | — |
| 044 | Services of medical, pharmaceutical or biotechnological laboratories, namely, services of a medical and pharmaceutical laboratory, in particular in connection with the manufacture of cell therapeutic agents, cell compounds, cell preparation, cellular medicines, the selection, stimulation, activation of cells, as well as the manufacture of kits or reagents, medical services, in particular the field of extracorporeal plasma therapy; medical treatment services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MILTENYI BIOMEDICINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 26, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 12, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 12, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 22, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 5, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 5, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 21, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 21, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 21, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 20, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 20, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 16, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 14, 2021 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Dec 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 14, 2021 | PETG | PETITION TO REVIVE-GRANTED | — |
| Dec 14, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Nov 22, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 22, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 22, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 22, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 22, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 1, 2021 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 1, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 9, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 8, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 5, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 4, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 4, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |